The healthcare corporation Bodyfriend reported a consolidated revenue of 436.8 billion won and an operating profit of 22.5 billion won for last year on the 31st. This is an increase of 41% in revenue and 34.6% in operating profit compared to the previous year.
Bodyfriend analyzed that the main driver of its performance rebound was the launch of new products through consistent research and development investment. The amount Bodyfriend invested in R&D last year was a total of 20 billion won, accounting for 4.5% of total revenue.
Based on this, Bodyfriend launched various new products last year, including the healthcare robots "Eden" and "Pharaoh Neo," and the medical device "Medical Pharaoh." Healthcare robots refer to a product line that utilizes robotic technology to elicit various movements across the body, stimulating muscles and providing core workouts.